Product Information
DOLISHALE 90-20 MCG TABLET is a generic product labeled by Ingenus Pharmaceuticals LLC, priced at $1.1357 per EA under NDC 50742065928. Its NADAC has been published 279 times since Jun 2, 2021.
FDA first approved this application on Oct 22, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20; 90 ug/1; ug/1
Manufacturer
Ingenus Pharmaceuticals LLCNDC
50742065928
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ETHINYL ESTRADIOL; LEVONORGESTRELApproval Type
Generic (ANDA)
FDA Application
ANDA091692FDA Approved
10/22/2020
TE Code
AB
On Market Since
1/3/2021
Pharmacological Classes
Price Statistics
The NADAC for DOLISHALE 90-20 MCG TABLET has been published 279 times since Jun 2, 2021, and over the history we have for it it has declined 6.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.1357 per EA |
|---|---|
| All-time high | $1.4130 (Nov 16, 2022) |
| All-time low | $0.7929 (Nov 20, 2024) |
| 52-week high | $1.2766 |
| 52-week low | $1.1357 |
| Median price | $1.2262 |
| Average price | $1.1784 |
| Largest weekly change | -28.9% (Nov 20, 2024) |
| Weeks tracked | 279 |
| Tracking since | Jun 2, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ingenus Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levonorgestrel and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Estrogen class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of DOLISHALE 90-20 MCG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DOLISHALE 90-20 MCG TABLET, manufactured by Ingenus Pharmaceuticals LLC, is $1.1357 per EA (NDC 50742065928), effective Sep 30, 2026.
How has the price of DOLISHALE 90-20 MCG TABLET changed over time?
Over the history we have for it, the NADAC for DOLISHALE 90-20 MCG TABLET has declined 6.2%. It has been tracked across 279 weekly CMS publications since Jun 2, 2021.
What are the highest and lowest recorded NADAC prices for DOLISHALE 90-20 MCG TABLET?
Since Jun 2, 2021, the NADAC for DOLISHALE 90-20 MCG TABLET has ranged from a low of $0.7929 (Nov 20, 2024) to a high of $1.4130 (Nov 16, 2022), with a median of $1.2262 per EA.
Are there cheaper alternatives to DOLISHALE 90-20 MCG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DOLISHALE 90-20 MCG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DOLISHALE 90-20 MCG TABLET?
DOLISHALE 90-20 MCG TABLET (NDC 50742065928) is labeled by Ingenus Pharmaceuticals LLC, and CMS classifies it as a generic product.